Stock listing
Maplight Therapeutics, Inc.
Selected listing: MPLT · NASDAQ · USD · US
Maplight Therapeutics, Inc. (NASDAQ:MPLT), Health Technology. Latest release Oct 6, 2026: MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth…
- Ticker
- NASDAQ:MPLT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Maplight Therapeutics, Inc.
The company focuses on developing innovative therapies aimed at improving patient outcomes. As a publicly traded entity, Maplight Therapeutics is positioned within the healthcare sector, contributing to advancements in medical treatments.
Latest news from Maplight Therapeutics, Inc.
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
October 6, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conference
September 9, 2026
MapLight Therapeutics Announces $150 Million Private Placement Financing
August 13, 2026
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
July 27, 2026
MapLight Therapeutics Announces Changes to Board of Directors
June 24, 2026
Research Maplight Therapeutics, Inc.
Maplight Therapeutics, Inc. company profile
View the public company page for Maplight Therapeutics, Inc. on 6ix.
Maplight Therapeutics, Inc. news
Read company news and market updates connected to Maplight Therapeutics, Inc..
Maplight Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Maplight Therapeutics, Inc..